CHICAGO — Mice love to run. But not when they’re taking semaglutide, the diabetes and weight-loss drug sold as Ozempic and Wegovy. While on the drug, mice ran less on a wheel in a cage, a new study shows.
The results, presented October 7 at the annual meeting of the Society for Neuroscience, are preliminary. Still, the unexpected finding raises questions about whether such increasingly popular drugs, which mimic a hormone called GLP-1, might be tinkering with people’s motivation to exercise (SN: 8/29/23).
.email-conversion { border: 1px solid #ffcccb; color: white; margin-top: 50px; background-image: url(“/wp-content/themes/sciencenews/client/src/images/[email protected]”); padding: 20px; clear: both; }